• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Abingworth

edit

Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies.

Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston.

Recent Milestones

edit

• 
  Abingworth invested in Effector Therapeutics. (5/20/13)
  Posted 5/20/13 at 5:21am via fiercebiotech.com
• 
  Abingworth invested in GenSight Biologics. (4/8/13)
  Posted 4/9/13 at 9:38pm via yahoo.com
• 
  Abingworth invested in Gynesonics. (2/20/13)
  Posted 2/20/13 at 7:27pm via dowjones.com
• 
  Abingworth invested in Avillion. (1/28/13)
  Posted 1/28/13 at 7:40pm via finsmes.com
• 
  Abingworth invested in Labcyte. (1/8/13)
  Posted 1/8/13 at 6:49pm via finsmes.com
• 
  Abingworth invested in Chiasma. (7/23/12)
  Posted 7/23/12 at 6:18pm via finsmes.com
• 
  Abingworth invested in Sonitus Medical. (5/15/12)
  Posted 5/16/12 at 8:02pm via sonitusmedical.com
• 
  Abingworth invested in Prosensa. (1/25/12)
  Posted 1/25/12 at 4:05am via reuters.com
• 
  Abingworth invested in Valeritas. (9/12/11)
  Posted 9/12/11 at 5:48pm via finsmes.com
• 
  Abingworth invested in MD On-Line. (5/18/11)
  Posted 5/20/11 at 5:32pm via mdon-line.com
• 
  Abingworth invested in Syntaxin. (11/11/10)
  Posted 11/11/10 at 6:27pm via fiercebiotech.com
• 
  Abingworth invested in IS Pharma. (10/7/10)
  Posted 10/7/10 at 6:04pm via dowjones.com
• 
  Abingworth invested in Pathwork Diagnostics. (10/6/10)
  Posted 10/7/10 at 9:23pm via dowjones.com
• 
  Abingworth invested in Oxagen. (11/24/09)
  Posted 11/25/09 at 4:32am via fiercebiotech.com
• 
  Abingworth invested in PrimeraDx. (10/30/09)
  Posted 10/30/09 at 5:51pm via onbiovc.com
• 
  Abingworth invested in Zogenix. (10/5/09)
  Posted 9/24/09 at 2:04am via sec.gov

Investments

Videos

Sources

1. Effector Therapeutics snags $45M venture round from A-list backers (fiercebiotech.com) [edit]
2. GenSight Biologics Raises €32m in a Series A Financing for Ophthalmic Gene Therapy (finance.yahoo.com) [edit]
3. Gynesonics Raises $21M Series D for Uterine Fibroid-Ablating Device (pevc.dowjones.com) [edit]
4. Avillion Receives Funding from Abingworth and Clarus Ventures (finsmes.com) [edit]
5. Labcyte Closes $5.3M Series D Financing (finsmes.com) [edit]
6. Chiasma Closes $38.5M Series D Equity Financing (finsmes.com) [edit]
7. Sonitus Medical Closes $25 Million Series D Round of Venture Capital Financing (sonitusmedical.com) [edit]
8. Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates (reuters.com) [edit]
9. Valeritas Raises $150m in Series C financing. (finsmes.com) [edit]
10. MD On-Line Announces Equity Investment from Abingworth (mdon-line.com) [edit]
11. VCs inject $29M into Syntaxin, $11.5M into Ceregene (fiercebiotech.com) [edit]
12. Public IS Pharma Takes In $5.7M From Abingworth In Private Placement (fis.dowjones.com) [edit]
13. Alta Partners Leads $30M Series C For Pathwork Diagnostics (fis.dowjones.com) [edit]
14. Oxagen rounds up $26.7M in VC (fiercebiotech.com) [edit]
15. PrimeraDx, Inc.: Series C $20M (onbiovc.com) [edit]
16. SEC D (sec.gov) [edit]
17. Intellikine, Inc.: Series B $51M (onbiovc.com) [edit]
18. Capital Report Index [edit]
19. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
20. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
21. Zogenix Raises $18 Million in Preferred Stock Financing (zogenix.com) [edit]
22. Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline (syntaxin.com) [edit]
23. Neurological co. Synosis raises $32.5M (deals.venturebeat.com) [edit]
24. CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING (chromatherapeutics.com) [edit]
25. EDGAR [edit]
26. Adiana, Inc. Reports Completion of $23 Million Financing. (allbusiness.com) [edit]
27. Broncus Technologies lines up venture debt financing for emphysema treatment (venturebeat.com) [edit]